Investor enthusiasm could hardly be higher heading into the second-quarter earnings report from Netflix (NASDAQ: NFLX). CEO Reed Hastings and his team tried to temper expectations following their first-quarter blowout, yet shares have still raced ahead to more than $500 in the w
At a conference in 2015, Netflix (NASDAQ: NFLX) CEO Reed Hastings famously predicted, "We will come to see that linear TV declines every year for the next 20 years and that internet TV rises every year for the next 20 years."
This week, Netflix (NASDAQ: NFLX) will help kick off earnings season. The streaming media company is slated to report its second-quarter results on Thursday, making it one of the first megacap stocks to report earnings for the second calendar quarter of 2020.
Stocks rose last week, as both the Dow Jones Industrial Average (DJINDICES: ^DJI) and the S&P 500 (SNPINDEX: ^GSPC) edged closer to positive territory for the year. Just a few days into the second half of 2020, the Dow is lower by 9% while the S&P is only down about 2%.
The second quarter earnings season of 2020 is finally here. One way or another, the list of concerns the market has had regarding the devastation the coronavirus pandemic had on corporate profits will be realized.
Though many COVID-19 drug and vaccine trials are under way today, there's no guarantee that they will be successful in the next year (or longer). Meanwhile, the long pandemic could also have huge, lasting effects, harming many industries, while also boosting the stocks of certai
With so many people staying home during the COVID-19 pandemic and needing to entertain themselves, Netflix (NASDAQ: NFLX) has emerged as an inadvertent beneficiary of the public health crisis. The video-streaming leader posted a massive (if unsurprising) spike in subscriber addi
With so many people staying home during the COVID-19 pandemic and needing to entertain themselves, Netflix (NASDAQ: NFLX) has emerged as an inadvertent beneficiary of the public health crisis. The video-streaming leader posted a massive (if unsurprising) spike in subscriber addi
The entertainment sector has been complicated in 2020. Some stocks crashed due to the COVID-19 pandemic, others surged because the same health crisis actually helped them, and many are stuck in between those extremes.
The entertainment sector has been complicated in 2020. Some stocks crashed due to the COVID-19 pandemic, others surged because the same health crisis actually helped them, and many are stuck in between those extremes.
Despite the brutal economic conditions that still have much of the economy on the sidelines, and the resurgence of COVID-19 cases in recent weeks, some of the most beaten-down stocks are leading today's charge higher for the S&P 500 (SNPINDEX: ^GSPC). The index ended the w
Despite the brutal economic conditions that still have much of the economy on the sidelines, and the resurgence of COVID-19 cases in recent weeks, some of the most beaten-down stocks are leading today's charge higher for the S&P 500 (SNPINDEX: ^GSPC). The index ended the w
U.S. stocks rose on Friday as a positive analysis on Gilead Sciences Inc's antiviral drug to treat COVID-19 helped to soothe investor worries over a record rise in coronavirus cases in the United States, and as financial shares surged.
U.S. stocks rose on Friday as a positive analysis on Gilead Sciences Inc's antiviral drug to treat COVID-19 helped to soothe investor worries over a record rise in coronavirus cases in the United States, and as financial shares surged.
U.S. stocks rose on Friday as a positive analysis on Gilead Sciences Inc's antiviral drug to treat COVID-19 helped to soothe investor worries over a record rise in coronavirus cases in the United States, and as financial shares surged.
U.S. stocks rose on Friday as a positive analysis on Gilead Sciences Inc's antiviral drug to treat COVID-19 helped to soothe investor worries over a record rise in coronavirus cases in the United States, and as financial shares surged.
U.S. stocks rose on Friday and the Nasdaq posted its sixth record closing high in seven days as a positive analysis on Gilead Sciences Inc's antiviral drug to treat COVID-19 soothed investor worries over a record rise in coronavirus cases in the United States.
U.S. stocks rose on Friday and the Nasdaq posted its sixth record closing high in seven days as a positive analysis on Gilead Sciences Inc's antiviral drug to treat COVID-19 soothed investor worries over a record rise in coronavirus cases in the United States.
What happened
Netflix (NASDAQ: NFLX) shares were flying higher today after investors woke up to a full-throated endorsement from Goldman Sachs. Analyst Heath Terry raised his price target on the stock from $540 to $670, and once again said it was on his Conviction Buy list.
What happened
Netflix (NASDAQ: NFLX) shares were flying higher today after investors woke up to a full-throated endorsement from Goldman Sachs. Analyst Heath Terry raised his price target on the stock from $540 to $670, and once again said it was on his Conviction Buy list.